Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
bill cassidy
boston blog main
boston top stories
deals
johnson & johnson
life sciences
mark warner
medicaid
meiragtx
2
×
national blog main
national top stories
new york blog main
new york top stories
novartis
spinal muscular atrophy
2
×
abiraterone
ac immune
achromatopsia
acorda therapeutics
aduro biotech
agenus
aldeyra therapeutics
aleksandra rizo
alexion pharmaceuticals
alzheimer's disease
apalutamide
atypical hemolytic uremic syndrome
beta-thalassemia
biogen
biotech
bluebird bio
boulder/denver blog main
boulder/denver top stories
caelum biosciences
cancer
cancer immunotherapy
celgene
chuck grassley
clinical trials
corvus pharmaceuticals
What
gene
2
×
age
alzheimer’s
bigger
biggest
bio
come
companies
deal
different
drug
emerging
fail
gave
increases
j
johnson
latest
meiragtx
morning
past
pharmaceutical
plan
prescription
price
prices
raise
roundup
signal
signals
start
therapies
therapy
typically
year
years
Language
Current search:
meiragtx
×
gene
×
" spinal muscular atrophy "
×
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy